Peptidomimetics in organic and medicinal chemistry /

"A peptidomimetic is a small protein-like chain designed to mimic a peptide with adjusted molecular properties such as enhanced stability or biological activity. It is a very powerful approach for the generation of small-molecule-based drugs as enzyme inhibitors or receptor ligands.Peptidomimet...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Trabocchi, Andrea (Συγγραφέας), Guarna, Antonio (Συγγραφέας)
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Chichester, West Sussex, UK ; Hoboken, NJ : John Wiley & Sons Inc., 2014.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04947nam a2200733 4500
001 ocn867001313
003 OCoLC
005 20170124070005.1
006 m o d
007 cr |||||||||||
008 131230s2014 enk ob 001 0 eng
010 |a  2013051081 
040 |a DLC  |b eng  |e rda  |c DLC  |d YDX  |d N$T  |d YDXCP  |d DG1  |d IDEBK  |d CUS  |d CDX  |d COO  |d OCLCF  |d E7B  |d EBLCP  |d OCLCQ  |d DEBBG  |d GrThAP 
066 |c (S 
019 |a 928632128 
020 |a 9781118683149 (ePub) 
020 |a 1118683145 (ePub) 
020 |a 9781118683842 (Adobe PDF) 
020 |a 1118683846 (Adobe PDF) 
020 |z 9781119950608 (hardback) 
020 |a 9781118683033 
020 |a 111868303X 
020 |a 1119950600 
020 |a 9781119950608 
020 |a 9781306546980 
020 |a 1306546982 
029 1 |a NZ1  |b 15497399 
029 1 |a NZ1  |b 15906664 
029 1 |a CHVBK  |b 33409531X 
029 1 |a CHBIS  |b 010442021 
029 1 |a DEBBG  |b BV043396448 
035 |a (OCoLC)867001313  |z (OCoLC)928632128 
042 |a pcc 
050 0 0 |a RS431.P38 
072 7 |a MED  |x 071000  |2 bisacsh 
082 0 0 |a 615.1/9  |2 23 
084 |a SCI013050  |2 bisacsh 
049 |a MAIN 
100 1 |a Trabocchi, Andrea,  |e author. 
245 1 0 |a Peptidomimetics in organic and medicinal chemistry /  |c Dr. Andrea Trabocchi and Professor Antonio Guarna. 
264 1 |a Chichester, West Sussex, UK ;  |a Hoboken, NJ :  |b John Wiley & Sons Inc.,  |c 2014. 
300 |a 1 online resource. 
336 |a text  |2 rdacontent 
337 |a computer  |2 rdamedia 
338 |a online resource  |2 rdacarrier 
520 |a "A peptidomimetic is a small protein-like chain designed to mimic a peptide with adjusted molecular properties such as enhanced stability or biological activity. It is a very powerful approach for the generation of small-molecule-based drugs as enzyme inhibitors or receptor ligands.Peptidomimetics in Organic and Medicinal Chemistry outlines the concepts and synthetic strategies underlying the building of bioactive compounds of a peptidomimetic nature. Topics covered include the chemistry of unnatural amino acids, peptide- and scaffold-based peptidomimetics, amino acid-side chain isosteres, backbone isosteres, dipeptide isosteres, beta-turn peptidomimetics, proline-mimetics as turn inducers, cyclic scaffolds, amino acid surrogates, and scaffolds for combinatorial chemistry of peptidomimetics. Case studies in the hit-to-lead process, such as the development of integrin ligands and thrombin inhibitors, illustrate the successful application of peptidomimetics in drug discovery"--  |c Provided by publisher. 
520 |a "Peptidomimetics in Organic and Medicinal Chemistry outlines the concepts and synthetic strategies underlying the building of bioactive compounds of a peptidomimetic nature"--  |c Provided by publisher. 
504 |a Includes bibliographical references and index. 
588 |a Description based on print version record and CIP data provided by publisher. 
505 0 |a Title Page; Copyright; Dedication; Preface; Abbreviations; Part I: The Basics of Peptidomimetics; Chapter 1: The Basics of Peptidomimetics; 1.1 Introduction; 1.2 Definition and Classification; 1.3 Strategic Approaches to Peptidomimetic Design; 1.4 Successful Examples of Peptidomimetic Drugs; 1.5 Conclusion; References; Chapter 2: Synthetic Approaches towards Peptidomimetic Design; 2.1 Introduction; 2.2 Local Modifications; 2.3 Global Restrictions through Cyclic Peptidomimetics; 2.4 Peptidomimetic Scaffolds; 2.5 Conclusions; References; Part II: Synthetic Methods and Molecules 
505 8 |a Chapter 3: Peptidomimetic Bioisosteres3.1 Introduction; 3.2 Peptide Bond Isosteres; 3.3 Side-Chain Isosteres; 3.4 Dipeptide Isosteres; 3.5 Tripeptide Isosteres; 3.6 Conclusion; References; Chapter 4: Solid-Phase Synthesis and Combinatorial Approaches to Peptidomimetics; 4.1 Introduction; 4.2 Solid-Phase Synthesis of Peptidomimetics; 4.3 Conclusion; References; Chapter 5: Click Chemistry: The Triazole Ring as a Privileged Peptidomimetic Scaffold; 5.1 Introduction; 5.2 Triazole-Containing Peptidomimetics Elaborated through 'Click Chemistry'; 5.3 Relevant Applications in Drug Discovery 
650 0 |a Peptide drugs. 
650 0 |a Proteins  |x Therapeutic use. 
650 0 |a Drugs  |x Design. 
650 7 |a SCIENCE / Chemistry / Physical & Theoretical.  |2 bisacsh 
650 7 |a Drugs  |x Design.  |2 fast  |0 (OCoLC)fst00898790 
650 7 |a Peptide drugs.  |2 fast  |0 (OCoLC)fst01057556 
650 7 |a Proteins  |x Therapeutic use.  |2 fast  |0 (OCoLC)fst01079767 
655 4 |a Electronic books. 
655 0 |a Electronic books. 
700 1 |a Guarna, Antonio,  |e author. 
776 0 8 |i Print version:  |a Trabocchi, Andrea, author.  |t Peptidomimetics in organic and medicinal chemistry  |d Chichester, West Sussex ; Hoboken, NJ : John Wiley & Sons Inc., 2014  |z 9781119950608  |w (DLC) 2013048681 
856 4 0 |u https://doi.org/10.1002/9781118683033  |z Full Text via HEAL-Link 
994 |a 92  |b DG1